Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|September 13, 2013
Development of peptide and protein based radiopharmaceuticalsEvelien Wynendaele, Nathalie Bracke, Sofie Stalmans, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|March 2, 2016
Biodistribution of the cyclotide MCoTI-II, a cyclic disulfide-rich peptide drug scaffoldConan K Wang, Sofie Stalmans, Bart De Spiegeleer, et al.Biopolymers|April 8, 2015
Exploring the chemical space of quorum sensing peptidesEvelien Wynendaele, Bert Gevaert, Sofie Stalmans, et al.Journal of Pharmaceutical Analysis|February 7, 2018
Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysisMatthias D'Hondt, Frederick Verbeke, Sofie Stalmans, et al.Regulatory Toxicology and Pharmacology : RTP|July 8, 2014
Flatworm models in pharmacological research: the importance of compound stability testingSofie Stalmans, Maxime Willems, Els Adriaens, et al.Protein and Peptide Letters|February 16, 2016
Exploration of the Medicinal Peptide SpaceBert Gevaert, Sofie Stalmans, Evelien Wynendaele, et al.Journal of Pharmaceutical and Biomedical Analysis|September 24, 2015
Quality control of cationic cell-penetrating peptidesSofie Stalmans, Bert Gevaert, Frederick Verbeke, et al.Ageing Research Reviews|February 23, 2016
Regulatory development of geriatric medicines: To GIP or not to GIP?Bart De Spiegeleer, Evelien Wynendaele, Nathalie Bracke, et al.Plos One|October 15, 2015
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In VivoSofie Stalmans, Nathalie Bracke, Evelien Wynendaele, et al.Plos One|August 17, 2013
Chemical-functional diversity in cell-penetrating peptidesSofie Stalmans, Evelien Wynendaele, Nathalie Bracke, et al.Pageof 3